Sancho-Balsells A, Garcia-Garcia E, Flotta F, Chen W, Alberch J, Rodriguez M
Mar Drugs. 2022; 20(10).
PMID: 36286471
PMC: 9605278.
DOI: 10.3390/md20100648.
Chen S, Underwood B, Jones P, Lewis J, Cardinal R
PLoS Med. 2022; 19(3):e1003941.
PMID: 35298477
PMC: 8929585.
DOI: 10.1371/journal.pmed.1003941.
Rodriguez-Urgelles E, Sancho-Balsells A, Chen W, Lopez-Molina L, Ballasch I, Del Castillo I
Front Pharmacol. 2022; 13:791666.
PMID: 35281935
PMC: 8908099.
DOI: 10.3389/fphar.2022.791666.
Wojewodka G, Gulliford M, Ashworth M, Richardson M, Ridsdale L
BMJ Open. 2021; 11(10):e052841.
PMID: 34697121
PMC: 8547505.
DOI: 10.1136/bmjopen-2021-052841.
Ishii N, Terao T, Hirakawa H
Int J Environ Res Public Health. 2021; 18(15).
PMID: 34360049
PMC: 8345730.
DOI: 10.3390/ijerph18157756.
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.
DMello S
Int J Mol Sci. 2021; 22(11).
PMID: 34072862
PMC: 8199025.
DOI: 10.3390/ijms22115911.
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study.
Desai R, Varma V, Gerhard T, Segal J, Mahesri M, Chin K
Alzheimers Dement (N Y). 2020; 6(1):e12095.
PMID: 33304987
PMC: 7690721.
DOI: 10.1002/trc2.12095.
Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review.
Carreira H, Williams R, Strongman H, Bhaskaran K
BMJ Open. 2019; 9(7):e029227.
PMID: 31270119
PMC: 6609128.
DOI: 10.1136/bmjopen-2019-029227.
The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: A systematic review.
McGuinness L, Warren-Gash C, Moorhouse L, Thomas S
Pharmacoepidemiol Drug Saf. 2019; 28(2):244-255.
PMID: 30667114
PMC: 6519035.
DOI: 10.1002/pds.4669.
The role of CA1 CB1 receptors on lithium-induced spatial memory impairment in rats.
Vaseghi S, Babapour V, Nasehi M, Zarrindast M
EXCLI J. 2018; 17:916-934.
PMID: 30564071
PMC: 6295625.
DOI: 10.17179/excli2018-1511.
Predicting dementia from primary care records: A systematic review and meta-analysis.
Ford E, Greenslade N, Paudyal P, Bremner S, Smith H, Banerjee S
PLoS One. 2018; 13(3):e0194735.
PMID: 29596471
PMC: 5875793.
DOI: 10.1371/journal.pone.0194735.
Potential application of lithium in Parkinson's and other neurodegenerative diseases.
Lazzara C, Kim Y
Front Neurosci. 2015; 9:403.
PMID: 26578864
PMC: 4621308.
DOI: 10.3389/fnins.2015.00403.
Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.
Huang Y, Wu Z, Zhou B
Cell Mol Life Sci. 2015; 73(1):1-21.
PMID: 26403791
PMC: 11108533.
DOI: 10.1007/s00018-015-2042-8.
Lentiviral silencing of GSK-3β in adult dentate gyrus impairs contextual fear memory and synaptic plasticity.
Chew B, Ryu J, Ng T, Ma D, Dasgupta A, Neo S
Front Behav Neurosci. 2015; 9:158.
PMID: 26157370
PMC: 4477161.
DOI: 10.3389/fnbeh.2015.00158.
Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.
Liu D, Ander B
ScientificWorldJournal. 2012; 2012():491737.
PMID: 22547985
PMC: 3323905.
DOI: 10.1100/2012/491737.
GSK-3β and memory formation.
Takashima A
Front Mol Neurosci. 2012; 5:47.
PMID: 22536172
PMC: 3332229.
DOI: 10.3389/fnmol.2012.00047.
Does lithium prevent Alzheimer's disease?.
Forlenza O, de Paula V, Machado-Vieira R, Diniz B, Gattaz W
Drugs Aging. 2012; 29(5):335-42.
PMID: 22500970
DOI: 10.2165/11599180-000000000-00000.
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.
Eldar-Finkelman H, Martinez A
Front Mol Neurosci. 2011; 4:32.
PMID: 22065134
PMC: 3204427.
DOI: 10.3389/fnmol.2011.00032.
GSK-3 in Neurodegenerative Diseases.
Lei P, Ayton S, Bush A, Adlard P
Int J Alzheimers Dis. 2011; 2011:189246.
PMID: 21629738
PMC: 3100544.
DOI: 10.4061/2011/189246.
Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain.
Lu Y, Li T, Qureshi H, Han D, Paudel H
J Biol Chem. 2011; 286(23):20569-81.
PMID: 21489990
PMC: 3121503.
DOI: 10.1074/jbc.M111.220962.